Riskpilot← Back to searchSign inGet full accessBIOLOGISK AS
ASActiveOrg 928677923Silje Stenstad Nilsen Kilden 14, 3118 TønsbergNon-specialised wholesale trade · NACE 4690Est. 20221 employees
Revenue 2024
NOK 3,3M
-2% vs 2023
EBITDA margin
-1.7%
-150% vs 2023
Equity ratio
31.9%
Financial strength
Net profit 2024
NOK -82K
-240% vs 2023
| Revenue | NOK 3,3M | -2% |
| EBITDA | NOK -57K | -150% |
| Net profit | NOK -82K | -240% |
| Total assets | NOK 544K | -14% |
| Equity | NOK 173K | -32% |
| Employees | 1 | — |
Legal name
BIOLOGISK AS
Org number
928677923
Legal form
Aksjeselskap
NACE code
4690 · Non-specialised wholesale trade
Founded
4. februar 2022
Share capital
NOK 120 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Import, eksport og salg av tjenester og produkter til hagebruksnæringen og tilstøtende områder samt engasjere seg i andre selskaper gjennom aksjeinvesteringer eller på annen måte.
Address
Silje Stenstad Nilsen Kilden 14, 3118 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 1 082 | 3 416 | 3 333 |
| Staff expenses | −474 | −846 | −1 003 |
| EBITDA | 109 | 115 | −57 |
| Depreciation & amort. | −0 | −8 | −8 |
| EBIT | 109 | 106 | −65 |
| Net financials | −3 | −24 | −17 |
| Profit before tax | 106 | 83 | −82 |
| Tax | 24 | 24 | 0 |
| Net profit | 82 | 59 | −82 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 537 | 629 | 544 |
| Equity | 197 | 256 | 173 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 340 | 374 | 370 |
| Total debt | 340 | 374 | 370 |
EBITDA margin
-1.7%
This company
15.8%
Market median
-111% vs market
20222024
Equity ratio
31.9%
This company
38.2%
Market median
+16% vs market
20222024
Return on equity
-47.5%
This company
18.4%
Market median
-358% vs market
20222024
Net profit margin
-2.5%
This company
8.1%
Market median
-131% vs market
20222024
Asset turnover
6.13×
This company
1.12×
Market median
+447% vs market
20222024
Debt / equity
2.14×
This company
0.62×
Market median
-245% vs market
20222024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Chairman | 2026 | |
| Chairman | 2022 | |
| Board of Directors | 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Biologisk Holding As
BIOLOGISK AS Board members of BIOLOGISK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Gabriela Rizo Lundberg | Board of Directors | 0 companies |
| Bjørn Petter Skjeltorp | Board of Directors | 0 companies |
| Espen Ueland Fjeld | Board of Directors | 0 companies |
| Ingunn Kristiansen Børresen | Chairman | 0 companies |
| Silje Stenstad Nilsen | Chairman | 0 companies |
| Kari Anne Berget | Board of Directors | 0 companies |